| MIF | macrophage inhibitory factor; melanocyte[-stimulating hormone]-inhibiting factor; maximum inspirator... |
|---|---|
| MIS | management information system; medical information service; meiosis-inducing substance; minimally in... |
| PIF | paratoid isoelectric focusing variant protein; peak inspiratory flow; proinsulin-free; prolactin-inh... |
| RIF | radiological interface; release-inhibiting factor; rifampin; right iliac fossa; rosette-inhibiting f... |
| TIP | thermal inactivation point; Toxicology Information Program; translation-inhibiting protein; tumor-in... |
| MIS | Muellerian inhibiting substance |
|---|---|
| MMMT | Malignant mixed Mullerian tumor |
| MMT | Mixed Mullerian Tumours |
| MD | Mullerian duct |
| PMDS | Persistent Mullerian Duct Syndrome |
| mullerian inhibiting substance | A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin. Synonym: mullerian inhibiting factor. (05 Mar 2000) |
|---|
| mullerian inhibiting factor | A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin. Synonym: mullerian inhibiting factor. (05 Mar 2000) |
|---|---|
| malignant mixed mullerian tumour | A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. Synonym: malignant mixed mullerian tumour. (05 Mar 2000) |
| persistent mullerian duct syndrome | <syndrome> Familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient mullerian inhibitory substance secondary to Sertoli cell defect. Synonym: hernia uteri inguinale. (05 Mar 2000) |
| mixed tumour, mullerian | A tumour, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of oestrogen has been postulated as a possible aetiological factor in this tumour. (holland et al., cancer medicine, 3d ed, p1703) (12 Dec 1998) |
| mullerian | <anatomy> Of, pertaining to, or discovered by, Johannes Muller. <anatomy> Mullerian ducts, the sustentacular or connective-tissue fibres which form the framework of the retina. Source: Websters Dictionary (01 Mar 1998) |
| mullerian adenosarcoma | <tumour> A tumour of the uterus or ovaries, of low grade malignancy, characterised by benign appearing glands and a sarcomatous stroma. (05 Mar 2000) |
| mullerian duct | <radiology> FEMALE, fallopian tubes, uterus, vagina Male, appendix testis, prostatic utricle anomalies: mullerian agenesis most likely to be absent uterus and vagina, incomplete fusion most likely to be bicornuate/double uterus, double vagina, both associated with renal agenesis Cf: wolffian duct (12 Dec 1998) |
| mullerian ducts | Two ducts of the embryo which empty into the cloaca, and which in the female develop into vagina, uterus and oviducts; in the male they disappear except for the vestigial vagina masculina and the appendix testis. (12 Dec 1998) |
| mullerian regression factor | Mullerian duct inhibitory factor, a non-steroidal substance of foetal testicular origin that acts unilaterally to inhibit development of the paramesonephric (mullerian) ducts and acts with testosterone to promote development of the vas deferens and related structures. (05 Mar 2000) |
| melanotropin release-inhibiting hormone | Inhibits synthesis and release of melanotropin. Synonym: melanotropin release-inhibiting hormone. Origin: melanotropin + G. States, stationary, + -in (05 Mar 2000) |
| growth hormone inhibiting hormone | <protein> Gastrointestinal and hypothalmic peptide hormone (two forms: 14 and 28 residues), found in gastric mucosa, pancreatic islets, nerves of the gastrointestinal tract, in posterior pituitary and in the central nervous system. Inhibits gastric secretion and motility: in hypothalamus/pituitary inhibits somatotropin release. (18 Nov 1997) |
| pituitary hormone release inhibiting hormones | Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. (12 Dec 1998) |
| msh release-inhibiting hormone | <chemical> An oligopeptide hormone produced in the hypothalamus that inhibits the release of melanocyte-stimulating hormone (msh). Chemical name: Melanostatin (12 Dec 1998) |
| prolactin-inhibiting factor | A substance of hypothalamic origin capable of inhibiting the synthesis and release of prolactin. Synonym: prolactin-inhibiting factor, prolactin-inhibiting hormone. Origin: prolactin + G. Stasis, standing still, + -in (05 Mar 2000) |
| prolactin-inhibiting hormone | A substance of hypothalamic origin capable of inhibiting the synthesis and release of prolactin. Synonym: prolactin-inhibiting factor, prolactin-inhibiting hormone. Origin: prolactin + G. Stasis, standing still, + -in (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|